15 May 2013
Curie-Cancer and Roche strengthen partnership to fast-track the development...
14 May 2013
ULIS launches thermal sensor array product line, within scope of European...
13 May 2013
2012 in review: Biocitech focuses on collaboration with regional players
Back to list of references
Sector(s): Biotech, Pharma, etc
Area(s) of expertise: Cardiovascular, Diabetes
Development of new chemical entities for patients affected by metabolic diseases and Type II diabetes with a primary focus on the inhibition of atherosclerotic plaque growth and instability, insulin resistance, glucose intolerance, and lipotoxic cardiomyopathy.